| ★ |  GLP-1s Move Beyond Diabetes as Core Kidney-Protective Therapy | | 80 | Estados Unidos | |
| 14 |  Rethinking GLP-1s: A Smarter Policy for Long-Term Metabolic Health | Metabolic Mind @metabolicmind | — | Estados Unidos | 88 |
| 8 |  GLP-1s: Overdosing, Side Effects & Long-Term Risks | Dr. Abud Bakri & Dr. Andrew Huberman | Huberman Lab Clips @hubermanlabclips | 237.4K | Estados Unidos | 88 |
| 3 |  GLP-1s and Cardiovascular Risk: What the Latest Evidence Reveals | Metabolic Mind @metabolicmind | 49.3K | Estados Unidos | 89 |
| 10 |  Ask A Cardiothoracic Surgeon: Know When NOT to Use GLP-1 Drugs 🚫❤️ | Michael Richman MD, MMM, FACS @michaelrichmanmd | 2.9K | Estados Unidos | 88 |
| 19 |  What are GLP-1 therapies? | World Health Organization (WHO) @who | 1.8K | — | 87 |
| 9 |  GLP-1 therapies for obesity care | World Health Organization (WHO) @who | 1.6K | — | 88 |
| 17 |  GLP-1 drugs may offer relief for women living with endometriosis | | 1.5K | — | 87 |
| 16 |  Retatrutide (The Next Generation GLP 1 Drug) | Dr. Marc Morris @drmarcmorris | 958 | Canadá | 87 |
| 2 |  GLP-1 Medications: What You Need to Know | DarioHealth @dariohealthwellbeing | 711 | Estados Unidos | 89 |
| 4 |  When Your Diabetes Medication is the Latest Craze: Updates and Navigating Drug Shortages | Stanford Health Care @stanfordhospital | 600 | Estados Unidos | 89 |
| 11 |  GLP-1 Therapies: Where We’ve Been & Where We’re Going | Conversations on Health Care @cohcpodcast | 541 | Estados Unidos | 88 |
| 15 |  GLP-1 Medications for Weight Loss: the Latest Research | DarioHealth @dariohealthwellbeing | 365 | Estados Unidos | 88 |
| 5 |  Rapid Evolution in GLP-1s and Therapeutics at ADA 2026 | | 171 | Estados Unidos | 88 |
| 1 |  GLP-1 Receptor Agonists Reshape CKD Treatment Sequencing, With Pranav Garimella, MD | | 151 | Estados Unidos | 94 |
| 7 |  FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 88 |
| 13 |  Secret Shopper Study Reveals GLP-1 Telehealth Gaps | | 70 | Estados Unidos | 88 |
| 12 |  GLP-1 Discontinuation in Type 2 Diabetes: What Happens When Patients Stop? | | 64 | Estados Unidos | 88 |
| 18 |  When to Add GLP-1 Receptor Agonists to Metreleptin in Lipodystrophy, With Lindsay Fourman, MD | | 44 | Estados Unidos | 87 |
| 20 |  Continuous Ketone Monitoring May Guide SGLT2i Use in T1D | | 33 | Estados Unidos | 87 |
| 6 |  GLP-1 use in ALZHEIMER'S. What's the DATA say? #glp1 #alzheimer #insulin | Data Driven Doug @datadrivendoug | 19 | Estados Unidos | 88 |